Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Operating Margin (2016 - 2025)

United Therapeutics (UTHR) has disclosed Operating Margin for 17 consecutive years, with 45.14% as the latest value for Q4 2025.

  • Quarterly Operating Margin rose 457299.0% to 45.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 46.89% through Dec 2025, down 1764.0% year-over-year, with the annual reading at 46.89% for FY2025, 96.0% down from the prior year.
  • Operating Margin hit 45.14% in Q4 2025 for United Therapeutics, down from 48.59% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 26010.0% in Q4 2023 to a low of 4527.85% in Q4 2024.
  • Historically, Operating Margin has averaged 1115.12% across 5 years, with a median of 48.39% in 2025.
  • Biggest five-year swings in Operating Margin: soared 2597427bps in 2023 and later plummeted -3053785bps in 2024.
  • Year by year, Operating Margin stood at 40.9% in 2021, then fell by -13bps to 35.73% in 2022, then skyrocketed by 72701bps to 26010.0% in 2023, then plummeted by -117bps to 4527.85% in 2024, then soared by 101bps to 45.14% in 2025.
  • Business Quant data shows Operating Margin for UTHR at 45.14% in Q4 2025, 48.59% in Q3 2025, and 45.64% in Q2 2025.